Success Stories: A Chinese Research Fellow in Medical Chemistry Acquires EB1A Approval in Just 28 Days, With Premium Processing Upgrade
Client’s Testimonial:
“That's great news!! I appreciate your help during this journey. Thank you!”
On May 23rd, 2023, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Fellow in the Field of Medical Chemistry (Approval Notice).
General Field: Medical Chemistry
Position at the Time of Case Filing: Research Fellow
Country of Origin: China
Approval Notice Date: May 23rd, 2023
Processing Time: 28 days (Premium Processing Requested)
Case Summary:
Our EB1A (Alien of Extraordinary Ability) client from China focuses on making advancements in drug discovery for major diseases such as cancer, and he has already greatly advanced the national interest through his contributions to research topics such as anti-cancer medication discovery and natural product synthesis. Working in the area, he has achieved a consistent and notable record of success and influence. His extraordinary accomplishments are strongly based on his extensive knowledge and experience in the field. With a Ph.D. in medicinal chemistry, he is a highly qualified advanced degree scientist with extensive experience in advanced organic chemistry, synthetic chemistry, and medicinal chemistry.
On the other hand, he has actively engaged his peers in the field of chemistry by authoring and co-authoring 23 peer-reviewed scientific articles and 1 patent that have been published in international journals, all of which have been cited at least 496 times across the world in some 35 countries.
Besides, he is a highly reputed expert in medicinal chemistry, as recognized by other professionals. For instance, he has been invited by the publishers of major journals to judge manuscripts as part of the peer-review process; he has completed 16 reviews, whose long record of achievements is relied upon to uphold the quality of scientific research. Peer review is a long-standing component of scientific publishing and is essential for supporting the highest standards of methodological rigor and scientific reasoning. As he has been invited to review multiple times, he is a trusted expert in the field.
Moreover, his cutting-edge scholarship addresses some of our nation’s and the world’s most pressing issues, including researching and treating types of cancer such as leukemia. His strong background in advanced organic chemistry, synthetic chemistry, medicinal chemistry, nuclear magnetic resonance, X-ray crystallography, computer-aided drug design, and high-throughput screening has allowed his research to be particularly original, resulting in his success in fundamentally transforming anti-cancer small molecule design, bioactive natural product synthesis, and drug discovery research. It is due to this that one of his 4 recommenders had the following to say about his work:
“I am among those researchers who found [client’s] research to be impactful. My colleagues and I included his findings in two of our published articles. At first, we relied on his method of synthesizing Lingzhiol in our total synthesis of Lingzhiol and its analogs. We cited his approach when modifying and hosting the synthetic route we established in our work. In another article, we cited his approach to synthesizing Lingzhiol in our radical-based synthesis of the molecule. Considering the wide influence of his research, it is undeniable that our client’s research is foundational for medicinal chemistry.”
Again, we were successful in conveying to USCIS that our client has employed these skills to great effect, making significant strides in the understanding of cancer mechanisms and treatments through his research. His reputation for excellence and insight have meant he stands out as a notable specialist in his domain, whose research is important for developing new therapeutic targets and frequently inspires the work of his peers. It was therefore affirmed that he should continue his research in the United States. His case was approved only 28 days after applying for the premium processing service upgrade. We are grateful to him for choosing North America Immigration Law Group to represent him in this case, and we wish him the best in his future endeavors.